BIODESIX INC
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-05.
0001193125-26-335036
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-05.
0001193125-26-449763
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 12 previous paragraphs and 13 current paragraphs.
11 unchanged; 0 reworded; 2 added; 1 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (2)
Current report
On August 12, 2026, Perceptive exercised all 375,000 outstanding warrants associated with the Perceptive Warrant, First Amendment Warrants, and the Sixth Amendment Warrants on a cashless basis and received 228,691 shares of the Company's common stock.
Current report
No underwriters were involved in the foregoing sale of securities. The common stock issued upon exercise of the Perceptive Warrant, First Amendment Warrants, and the Sixth Amendment Warrants was issued in reliance upon the exemption from registration provided by Section 3(a)(9) under the Securities Act. The resale by Perceptive of the common stock issued upon exercise of these warrants was registered with the Securities and Exchange Commission on Form S-3 (Registration No. 333-296122), filed on May 21, 2026. We will not receive any proceeds from resales by Perceptive.